Prognosis
Lucrative Drug Trials Prompt Hospitals to Join Forces
- Consortiums hope to compete with large urban medical centers
- Drugmakers can pay more than $10,000 per patient for trials
This article is for subscribers only.
Small hospitals need money. Drug companies need patients for tests. Both sides say they’ve found a solution.
Regional hospitals across the U.S. are banding together to make it easier for pharmaceutical companies to use their facilities for clinical trials, a strategy that could boost revenue and give drugmakers increased access to patients.